Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

US (NV): Producer prioritizes sustainability at Nevada based cultivation and processing facility

Item 9 Labs Corp. announced its medical cannabis cultivation and processing facility Strive Wellness of Nevada will prioritize sustainable initiatives throughout construction.

Item 9 Labs broke ground on the project in April 2019 and will be producing legal medical cannabis products under organic practices by Q4. Located in Pahrump, Nevada, the 20,000 square-foot operation includes distribution rights.

“It is incredibly rewarding to see the Nevada cultivation and processing facility come to life,” stated CEO Sara Gullickson. “Ultimately, this license led me to forge my partnership with Item 9 Labs, which has evolved into a strong relationship of shared values and vision. Together, we are bringing best of industry practices to operations across the country.”

In November 2018, Item 9 Labs partnered with Bowden Investment Group to assist with environmentally friendly building strategies. The group is noted for constructing the first 100% sustainable apartment complex in Scottsdale, Arizona.

“With such a great and natural product under the roof, it only makes sense to combine a sustainable approach to the way we build and outfit the facility with the best materials and the latest, most efficient equipment for growing,” stated Andrew Bowden, CEO of Bowden Investment Group and Item 9 Labs board member.

Bowden Investment Group is currently enhancing Item 9 Labs’ Arizona cultivation and processing facility by introducing state-of-the-art custom environmental and irrigation controls, as well as an upgraded lighting system to increase efficiency and reduce energy use.

Item 9 Labs will be operating as licensed dispensaries, cultivation, and manufacturing facilities in a projected six to ten U.S. markets by the end of 2019.

For more information:
Item 9 Labs Corp
(602)463-4246
[email protected]  
item9labscorp.com  


Publication date: